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Accepted 16 March 2009AbstractObjective: Determining ‘‘minimally important change’’ (MIC) facilitates the interpretation of change scores on multi-item instruments.
This article focuses on how MIC values should be interpreted when applied to individual patients.
Study Design and Setting: The MIC value of a hypothetical questionnaire ‘‘Q’’ was determined in a sample of 400 patients who im-
proved and 100 patients who did not improve, using the receiver operating characteristic (ROC) method, and three methods to quantify the
uncertainty.
Results: The MIC value on questionnaire Q was 10.5. Firstly, the 95% confidence interval (CI) of the MIC value (for questionnaire Q:
5.6e14.2) quantifies the uncertainty of the estimation of the MIC value. Secondly, ‘‘how sure we are that this MIC value holds for every
patient’’ is quantified by the values for sensitivity (74%) and specificity (91%). Thirdly, the smallest detectable change (SDC) on question-
naire Q is calculated (16.0) to consider whether the MIC value (10.5) falls outside or within the measurement error.
Conclusion: For application in clinical research and practice, MIC values are always considered at the individual level, but determined
in groups of patients. The interpretation comes with different forms of uncertainty. To appreciate the uncertainty, knowledge of the under-
lying distributions of change scores is indispensable.  2010 Elsevier Inc. All rights reserved.
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Patient-reported outcomes, such as health-related quality
of life or perceived disability, are increasingly used in re-
search and clinical practice. These patient-reported out-
comes are often measured by multi-item questionnaires.
In addition to validity, reliability, and responsiveness, it is
important that the numerical value of an outcome measure
is interpretable. This means that users understand the mean-
ing of the measurement results [1]. In case of multi-item
questionnaires, it is not immediately clear how the observed* Corresponding author. Department of Epidemiology and Biostatis-
tics, EMGO Institute for Health and Care Research, VU University Med-
ical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The
Netherlands. Tel.: þ31-20-444-8176; fax: þ31-20-444-6775.
E-mail address: hcw.devet@vumc.nl (H.C.W. de Vet).
0895-4356/10/$ e see front matter  2010 Elsevier Inc. All rights reserved.
doi: 10.1016/j.jclinepi.2009.03.011scores and changes in scores should be interpreted. Assume
that we use a 10-item questionnaire to assess physical func-
tioning in a patient with low back pain, with a total score
ranging from 0 to 50 points. What does a score of 35 points
or a change score of 5 points mean? Therefore, we want to
know which change scores on such outcome measures are
minimally important. Jaeschke et al. [2] defined minimal
clinical important difference (MCID) as ‘‘the smallest dif-
ference in score in the domain of interest which patients
perceive as beneficial and which would mandate, in the
absence of troublesome side effects and excessive cost,
a change in the patient’s management.’’ This definition
appears to refer to changes that patients perceive as benefi-
cial and the consequences thereof for the management of
individual patients. The OMERACT group [3] and De
Vet et al. [4] have pointed out the distinction between
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Determining ‘minimally important change’ (MIC) fa-
cilitates the interpretation of changes scores on multi
item instruments.
MIC values are usually applied to individual patients
in research and clinical practice.
This paper provides three methods to quantify the un-
certainty in the application of MIC values to individ-
uals: 95% CI, sensitivity and specificity, and whether
the MIC value exceeds the measurement error.
differences between individuals (or groups) and changes
within individuals (or groups). Therefore, we prefer the
term minimally important change (MIC) for use in clinical
practice, where it concerns changes within patients.
In the literature, there is considerable confusion about
the values of MIC for group level and for individual level.
This confusion concerns three issues. Firstly, what exactly
is meant by group level, and what is individual level? Sec-
ondly, it is questioned whether different methods should be
used to determine the MIC value for groups and for individ-
uals, as suggested by Wells et al. [5]. Thirdly, there is con-
fusion whether the MIC values that are determined in
groups of patients differ from those applied to individual
patients. It has been suggested that MIC values will be
higher when applied to individual patients than to groups
of patients [6], but, interestingly enough, also the other
way around [7]. Therefore, we felt the need to explain
the difference between MIC values at group level and those
at individual level. In addition, we elaborate on how MIC
values can be applied and interpreted for individual patients
in clinical practice.2. Minimally important change at group level and
individual level
Methods proposed for the assessment of MIC values can
be broadly classified as anchor-based and distribution-
based methods [8,9]. Anchor-based methods use an exter-
nal criterion (anchor) to determine what patients (or their
clinicians) consider to be the MIC and relate the changes
on the measurement instrument to this criterion. Distribu-
tion-based methods relate the observed change to some
form of sample variability or to the measurement error of
the measurement instrument [9]. As distribution-based
methods lack information whether the observed changes
are minimally important, anchor-based methods are usually
preferred to determine the MIC values, whereas distribu-
tion-based methods provide supportive evidence [10,11].
Whatever method is applied, MIC values are always
determined in groups of patients, either in randomizedcontrolled trials (RCTs) or in other longitudinal studies.
However, the fact that the MIC is determined in a group of
patients does not say anything about the level on which the
MIC is applied. According to Guyatt et al. [1], classification
as MIC for group level or individual level depends on the
level on which the anchor is chosen. They made a distinction
between population-focused and individual-focused ap-
proaches. A population (group)-focused approach needs an
anchor at group level and an individual-focused approach
needs an anchor at individual level. For example, a popula-
tion-focused approach is needed for the question ‘‘How much
reduction in body weight results in a minimally important ef-
fect on disease incidence or mortality?’’ In this example, the
anchors are disease incidence or mortality at population
level. This kind of approach is often used in the public health
field. An individual-focused approach requires an anchor at
the individual level to determine which changes are mini-
mally important for individual patients. For example, an in-
dividual-focused approach is needed for the question
‘‘How much reduction in body weight results in a minimally
important improvement in physical functioning in an individ-
ual patient?’’ In this case, the patient-perceived increase in
physical functioning of each individual patient is assessed
and used as anchor. In clinical research and practice, an indi-
vidual-focused approach mostly applies.
Suppose that in an RCT, for comparing two interventions
to treat low back pain, the Roland Disability Questionnaire
(RDQ) is chosen as primary outcome measure and a mean
difference of 3 points is found between the two treatment
groups. Low back researchers reached consensus that the
MIC value for the RDQ is 5 points [12]. How do we use
MIC values for the interpretation of these results?
First question is whether this concerns MIC at group
level or at individual level. RCTs, like this one, are typi-
cally aimed to find the best treatments for individual
patients. For this reason, MIC at individual level should
be considered here. However, a comparison of the differ-
ence in group means, with an MIC based on an anchor at
individual level, is not the right thing to do. The reason is
that underlying a mean difference of 3 points on the
RDQ, there is a distribution of individual change scores,
for example, before and after treatment, in both trial arms.
Some of these changes may be small, and others may be
substantial. Some may be clinically unimportant, and others
may be clinically important. Guyatt et al. [13] have
explained how an MIC value can be used as a response cri-
terion in the analyses of trials. One determines for each
patient whether the change is larger or smaller than the
MIC value, and calculates for each trial arm the proportion
of patients whose scores exceed the MIC value, that is,
more than 5 points on the RDQ. Subsequently, one can
assess the proportion of success in each trial arm and calcu-
late risk differences and number of patients needed to treat
by making use of the MIC as a response criterion. This is
the way to apply MIC values at individual level in the inter-
pretation of RCTs. To determine whether differences
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sary to have an anchor at population level.
After this explanation of the difference between MIC
values at group level and individual level, the remainder
of the article focuses on how MIC values can be applied
and interpreted for individual patients in clinical practice.
For this purpose, we present a fictive example. The advan-
tage of a fictive example over a real example is that full
attention can be paid to specific methods to express uncer-
tainty around the MIC values, not confused and distracted
by comments about the practicalities of a specific example.
Finally, in the Discussion section, we will elaborate on the
additional challenges that occur with a real example, and
reflect on the methods that can be used to interpret MIC
values for individual patients.3. Intermezzo: the fictive example
3.1. Methods
Suppose that, in a longitudinal study, 500 patients with
low back pain complete the hypothetical questionnaire Q
on physical functioning on two occasions: before and after
treatment. From these patients, we have information on an
anchor as to whether their physical functioning remained
stable or showed slight or much improvement or deteriora-
tion. The anchor is considered to be a perfect gold standard
in this example. Questionnaire Q is a 10-item question-
naire, and each item is scored on a 6-point scale ranging
from 0 (unable) to 5 (no trouble). The total score, obtained
by summing the item scores, ranges from 0 (very poor
physical functioning) to 50 (perfect physical functioning).
Table 1 shows the mean change scores and standard devia-
tions (SDs) of questionnaire Q for the categories on the an-
chor. The Spearman correlation coefficient between the
anchor and the change scores on the measurement instru-
ment is 0.67. We generated the data by assuming a normal
distribution of change scores of questionnaire Q withinTable 1
Mean values and standard deviations (SDs) of the questionnaire Q for










Completely recovered 100 30 (15) 31.50 (15.45)
Much improved 200 20 (15) 19.73 (14.55)
Slightly improved 100 10 (10) 10.25 (9.45)
Not changed 75 0 (10) 0.47 (9.73)
Slightly deteriorated 25 10 (10) 12.00 (8.42)
Much deteriorated 0 0 0
Worse than ever 0 0 0
Importantly improved group 400 20 20.30 (15.50)
Not importantly improved
group
100 2.5 3.35 (10.60)each category. For example, the 200 patients in the category
‘‘much improved’’ according to the anchor were assigned
values by SPSS, leading to a mean value of 20 and an
SD of 15. Both the intended and the resulting means and
SDs are presented in Table 1.
3.1.1. Data analysis
To estimate the MIC value, we used the receiver operating
characteristic (ROC) method [14], visualized by the anchor-
based MIC distribution [15]. The ROC method is an anchor-
based method, which draws a parallel with diagnostic studies
[14]. The change score on questionnaire Q is the diagnostic test
result, diagnosing the occurrence of important improvement.
The anchor is used as the reference standard. On our anchor,
we have categories of patients who are completely recovered,
much improved, slightly improved, unchanged in health
status, slightly deteriorated, much deteriorated, and worse than
ever. In this fictive example, there were no patients with any
substantial deterioration in their physical functioning. We de-
cided to label patients who reported on the anchor to be slightly
improved, much improved, or completely recovered as ‘‘im-
portantly improved,’’ and patients who reported to be not
changed or slightly deteriorated as ‘‘not importantly im-
proved-.’’ The distributions of the change scores of the
‘‘importantly improved’’ patients and the ‘‘not importantly im-
proved’’ patients are visualized in a graph representing the an-
chor-based MIC distribution [15]. The MIC value corresponds
to the optimal ROC cutoff point, that is, the value for which the
sum of the percentages of false-positive and false-negative
classifications ([1 sensitivity]þ [1 specificity]) is small-
est. The MIC value is based on the empirical ROC curve. Its
95% confidence interval (CI) was obtained by nonparametric
bootstrapping (bias corrected and accelerated percentile
method) [16,17]. Bootstrapping yields an empirical distribu-
tion of the optimal cutoff score, and the boundaries of the
95% CI are given as the 2.5% and 97.5% percentiles.
3.2. Results
3.2.1. Determining the minimally important change
value
The anchor-based MIC distribution for questionnaire Q is
depicted in Fig. 1. The distribution of the change scores of the
400 patients who showed ‘‘important improvement’’ accord-
ing to the anchor is presented on the left-hand side, and the
distribution of the 100 patients who showed ‘‘no important
improvement’’ according to the anchor is presented on the
right-hand side. Note that for the estimation of the ROC cut-
off point, the distributions of both curves have equal sizes,
that is, it is not the absolute number of patients that is depicted
but the fraction of patients (relative frequencies). In addition,
note that, to form the group of ‘‘importantly improved’’ pa-
tients, not only the category of ‘‘slightly improved’’ patients
is used, but also the categories of ‘‘much improved’’ and
‘‘completely recovered’’ patients are added, because the cat-






































Fig. 1. Anchor-based minimally important change (MIC) distribution of the questionnaire Q with indication of the receiver operating characteristic cutoff
point at MIC 5 10.5. At this point, sensitivity 5 0.74 and specificity 5 0.91. For each curve, the relative frequency is presented. Solid curve represents im-
portantly improved patients and dotted curve represents not importantly improved patients.
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tainly wants to label these as false negatives. By the same to-
ken, the category of patients who showed deterioration is
included in the group of ‘‘not importantly improved’’ pa-
tients. The optimal ROC cutoff point lies at a change score
on questionnaire Q of 10.5 points. In that case, 26% of the pa-
tients who are ‘‘importantly improved’’ according to the an-
chor are misclassified as ‘‘not importantly improved’’
(sensitivity 5 74%), and 9% of the patients who are ‘‘not im-
portantly improved’’ according to the anchor have a higher
change score, and are misclassified as ‘‘importantly im-
proved’’ (specificity 5 91%). Thus, the MIC value on ques-
tionnaire Q is 10.5 points. Now that we have determined
the MIC value in this group of patients, we will explain the
application and interpretation at individual level.3.2.2. Application of minimally important change at
individual level: an analogy with diagnostic tests
To identify the best cutoff point for a diagnostic test in
clinical research, the results of the reference test and the
diagnostic test under study are examined in groups of
patients. The cutoff point is assessed by minimalizing or find-
ing an optimal trade-off of the percentages of false-positively
and false-negatively classified patients. This optimal cutoff
point found in research on groups of patients is applied to in-
dividual patients in clinical practice. Sensitivity and specific-
ity, and positive and negative misclassifications are expressed
as percentages in groups of patients, and translated into prob-
abilities for interpretation at individual level. Hence, going
from groups of patients to individual patients in diagnostic
studies, the cutoff points remain the same, and the interpreta-
tion shifts from proportions to probabilities.
The same reasoning applies to the MIC value determined
by the ROC method. Hence, MIC values determined in
a diagnostic approach will remain the same when appliedto individual patients. The challenge lies in the interpretation
of change scores in individuals even when also here the inter-
pretation shifts from proportions of misclassifications in
groups of patients to probabilities in individual patients. Note
that, for determining cutoff points in diagnostic tests and for
determining MIC values (both at individual level), groups of
patients are needed. However, this is different from determin-
ing MIC at group level, because in that case, a population-
focused anchor is needed.3.2.3. Interpretation of minimally important change
values at individual level
In clinical practice, one has to interpret the change score
of an individual patient in relation to the MIC value. The
clinician wants to know the probability that, for example,
after treatment, a patient has importantly improved, given
the observed change score. Suppose that a patient has
a change score of 10.5 points, that is, exactly the same
value as the MIC. In that case, the probability of this
change score in the group of patients who have importantly
improved is exactly the same as that in the group of patients
who have not importantly improved. A probability of
a change score smaller than the MIC value, for example,
5, is greater in the group of ‘‘not importantly improved’’
patients than in the group of ‘‘importantly improved’’
patients, and a probability of a change score larger than
the MIC value, for example, 15, is greater in the ‘‘-
importantly improved’’ group than in the ‘‘not importantly
improved’’ group. This is clearly illustrated in the anchor-
based MIC distribution (Fig. 1). The probability of a change
score of 20 is very unlikely in the ‘‘importantly im-
proved’’ group, and a change score of more than 30 points
is highly unlikely in the group of ‘‘not importantly
improved’’ patients. How certain one needs to be, greatly
depends on the consequences in patient care.
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values at individual level
The interpretation of MIC values at individual level is
accompanied by uncertainties. An important question there-
fore is: how confident are we about the MIC values? The
uncertainty or confidence can be expressed in three ways:
A. What is the 95% CI around the MIC value?
B. How sure are we that the MIC value applies to every
patient?
C. Does the MIC value exceed the measurement error
(i.e., is a change equal to the MIC value statistically
significant?)Re A: what is the 95% confidence interval around the min-
imally important change value? An MIC value obtained in
a group of patients should be accompanied with a 95% CI
value, which gives an indication of the sampling variation.
If the MIC is estimated in a small sample of patients, the
95% CI will be larger, and consequently, the uncertainty
whether this is the ‘‘true’’ value increases. The 95% CI
for the MIC value was 5.6e14.2.
Re B: how sure are we that the minimally important change
value applies to every patient? The answer to the question
about how sure we are that the MIC value applies to every pa-
tient is illustrated in Fig. 2. On the left-hand side, there is the
situation that resembles Fig. 1: the measurement instrument
is quite well able to distinguish patients who are importantly
improved from patients who are not importantly improved.
The MIC value classifies most of the patients correctly. On
the right-hand side, there is considerable overlap between
the two curves, and although the MIC value may be the same
as in the left-hand figure, the percentage of misclassified pa-



























Fig. 2. Two examples of an anchor-based MIC distribution with the same value
misclassification; right-hand side: much misclassification.means that the extent to which the MIC value determined
in a group of patients applies to every individual can be ex-
pressed by the sensitivity and specificity.
Re C: does the minimally important change value exceed
the measurement error? A third interpretation of confidence
is the question of whether we are confident that the patient has
really changed when he or she has an observed change that is
at least equal to the MIC value. In other words, is the magni-
tude of the MIC value larger than the measurement error? The
patients who did not change according to the anchor show an
SD of the change scores (SDchange) of 9.73 (Table 1). The
smallest detectable change (SDC) [18,19], that is, the change
beyond measurement error 5 1.64  SDchange 5 16.0, in
which 1.64 represents the z-score corresponding to 95% CI
(one-sided). Therefore, values larger than 16.0 points can
be considered to exceed the measurement error.4. Discussion
We will first reflect on the confusion in the literature
against the background of the methods we have proposed
here. Then, we will justify the use of the ROC method,
complemented with the anchor-based MIC distribution,
and discuss the practicalities of choosing an adequate
anchor and defining MIC on that anchor. We will finish
with comments about the uncertainties that accompany
the application of MIC values to individual patients.4.1. Confusion in the literature about minimally
important change at group level and individual level
An MIC value at group level can only be obtained by







for the MIC, but different underlying distributions. Left-hand side: little
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anchor is at the individual level. Drawing a parallel with
determining and applying cutoff points in diagnostic tests,
we have argued that the MIC value as assessed in groups
of patients is the best estimate of the MIC value for individ-
ual patients. However, some confusion has been created in
the literature by authors who have distinguished MIC
methods and MIC values for group level and individual
level. On behalf of the OMERACT group, Wells et al. [5]
classified different methods for assessing MIC in methods
at group level and at individual level. Without sound argu-
ments, the ROC method, for example, was labeled as indi-
vidual level, as was the reliable change index (RCI),
whereas the ‘‘mean change’’ method was labeled as ‘‘group
level’’ (see the following section for a description and dis-
cussion of these methods). However, for both the ‘‘mean
change’’ method and the ROC method, the MIC value is
determined in groups of patients, and one can subsequently
categorize individual patients as below or above this MIC
value. Hence, both methods determine the MIC value in
groups of patients, and both can be applied in the same
manner to individual patients.
With regard to the magnitude of the MIC values, Nor-
quist et al. [6] recommended MIC values which are 1.96
times higher at individual level, that is, for clinicians using
information on health-related quality of life to make deci-
sions about individual patients. In contrast, Wyrwich
et al. [7] proposed a 50% CI at individual level and 90%
or 95% CIs at group level, that is, smaller MIC values for
use in individual patients. Hence, both larger and smaller
MIC values have been proposed for the individual level.
Like others [1,20], we argued that the group and individual
levels have the same MIC value, but that more caution is
needed for the interpretation at individual level because
of accompanying uncertainties.4.2. Overview of other anchor-based methods to
determine the minimally important change value
In the Introduction section, we already stated that the
advantage of anchor-based methods is the link with an anchor
which defines minimally important change (MIC). However,
besides the ROC method, there are other anchor-based
methods to estimate the MIC value. A frequently used
method is the ‘‘mean change’’ method (adapted from
Jaeschke et al. [2]), which takes the mean change score on
the measurement instrument for the subcategory of patients
who are minimally importantly changed according to the an-
chor. In our example, the MIC value would have been 10.
However, this ‘‘mean change’’ method only provides infor-
mation about the subcategory of patients who have mini-
mally importantly improved, and gives no information
about the change scores of the patients who are not impor-
tantly improved according to the anchor. Therefore, it be-
comes impossible to quantify the probabilities of
‘‘importantly improved’’ vs. ‘‘not importantly changed.’’Of course, it is clear that the probability of an important
change in patients with a change score above the MIC value
will be high, but patients with a score below the mean MIC
value may still have a higher probability of belonging to
the importantly improved group than to the not importantly
improved group. This hampers the interpretation of MIC
values obtained by the ‘‘mean change’’ method for individual
patients.
Another method is the RCI proposed by Jacobson and
Truax [21] to measure individual change. They distinguish
clinical relevance and statistical significance. The first step
establishes clinical relevance using a cutoff point based on
the norm values of a patient/dysfunctional population and
a nonpatient/functional population. The second step is in-
tended to investigate statistical significance by assessing
whether the RCI is higher than 1.96. The formula for
RCI is (observed change)/SDdiff [22]. The norm values
for nonpatient/functional populations and for patient/dys-
functional populations are often lacking, and this hampers
the use of this method. Moreover, it answers the question
of whether patients completely recover, in terms of coming
in the range of nonpatients rather than whether they
experience an MIC.
Another way of calculating the MIC is based on linear
regression analysis in which one determines the MIC by es-
timating the mean change in the instrument corresponding
to the known MIC of a similar instrument (anchor) [23].
This method avoids the dichotomization or classification
on the anchor. However, this is only possible when there
is already a similar instrument for which the MIC value
is known. This hampers a broad applicability. Using this
method, a 95% CI can be calculated around the MIC value,
but it is difficult to quantify the uncertainty when applied to
individual patients: it remains unknown whether the MIC
value exceeds the measurement error, and it does not pro-
vide the probability of a false classification.4.3. The anchor-based minimally important change
distribution is the preferred method to estimate the
minimally important change for application at
individual level
We chose to supplement the ROC method with a graph-
ical presentation of the anchor-based MIC distribution,
because this method combines the advantages of both the
anchor-based and the distribution-based methods [15].
Especially in the application at individual level, the an-
chor-based MIC distribution shows a number of important
issues concerning levels of uncertainty, which remain
invisible when applying other methods.
1. One can see in the anchor-based MIC distribution
that, in our example, the MIC value of 10.5 points
is substantially smaller than the SDC, and thus, lies
within the measurement error. This means that an
observed change in a patient of 15 points, which is
43H.C.W. de Vet et al. / Journal of Clinical Epidemiology 63 (2010) 37e45a value between 10.5 and 16.0 points, although higher
than the MIC value, may be a chance finding, that is,
lies within the 95% distribution of the ‘‘not impor-
tantly improved’’ group. However, such a value is
more probable for a patient in the group of ‘‘impor-
tantly improved’’ patients than for a patient in the
group of ‘‘not importantly improved’’ patients. There-
fore, this does not disqualify the use of this MIC
value in clinical practice, unless one values false-
positive classifications (i.e., statistical significance)
much higher than false-negative classifications.
2. The anchor-based MIC distribution also illustrates the
narrowness of the curves, and consequently, the over-
lap of the curves for the ‘‘importantly improved’’
group and the ‘‘not importantly improved’’ group.
Both depend largely on the correlation between the
scores on the anchor and the measurement instru-
ment. Values over 0.30e0.35 [11] and over 0.5
[24,25] have been proposed. In our opinion, values
over 0.5 are necessary to prevent too much overlap
in the curves and retain reasonable sensitivity and
specificity underlying the MIC value. In a previous
study, we found sensitivities and specificities of
around 0.70 when the correlation between anchor
and measurement instrument was in the range of
0.50e0.60 [26]. In this example, the Spearman corre-
lation coefficient between questionnaire Q and the
ordinal scale of the anchor was 0.67.
3. The relevant question in clinical practice is whether
a patient has experienced at least an important
improvement, given the observed change score. This
refers to the predictive value of that change score,
which is defined as: given this change score, what
is the probability that this patient has importantly im-
proved? From diagnostic studies, we know that this
predictive value depends on the prevalence of impor-
tant improvement. Therefore, for a proper interpreta-
tion, the clinician should have an idea about the
clinical course of the disease or the effectiveness of
































Fig. 3. Distribution of change scores on questionnaire Q in importantly improved
improved patients and dotted curve represents not importantly improved patientsfrom the anchor-based MIC distribution, using abso-
lute numbers of patients to draw the curves (Fig. 3)
instead of the relative frequencies shown in Fig. 1.
The two curves should then be presented based on
the sample sizes of the categories of ‘‘not importantly
improved’’ patients (n 5 100) and ‘‘importantly im-
proved’’ patients (n 5 400).
4. Until now, we have set the ROC cutoff point where
the proportion of negative and positive misclassifica-
tion is the smallest. However, the consequences of
positive and negative misclassification may be differ-
ent. For example, if the consequence of nonimportant
improvement is surgery, and a wait-and-see policy
does not harm, raising the cutoff point may be more
sensible, leading to a higher MIC value. In this
way, one reduces the probability of false-positive
values, and increases the certainty that a patient has
changed if that value is exceeded. In this example,
one might require a statistically significant deteriora-
tion before deciding to perform an invasive operation.4.4. Practicalities in the choice of the anchor and
defining ‘‘minimally important change’’ on that anchor
We intentionally used a fictive example, because the
choice of the anchor and the cutoff point for the definition
of minimal importance often gives rise to much discussion.
A global rating provided by patients with regard to changes
in (specific aspects of) their health status is often used.
Such a global rating scale closely links up with the phrase
‘‘perceived beneficial by patients’’ in the definition of
Jaeschke et al. [2]. However, critical remarks have been
made about such a transition question; firstly, about its
reliability because it consists of only one question [27],
and secondly, about the fact that it tends to depend more
on the most recent measurement than on the first measure-
ment, which is an indication of recall bias [28]. We want to
stress, however, that other anchors can be used. For exam-
ple, Cella et al. [29] used a number of clinical outcomes,
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ment questionnaire for lung cancer patients.
The anchors often measure magnitudes of changes,
whereas the concept of MIC concerns importance of
change. In the literature, studies using a global rating scale
have used different cutoff points for defining MIC. Wyr-
wich et al. have elegantly shown how the definition of the
anchor influences the value of MIC [7].4.5. Comments on the uncertainty around the
minimally important change estimations applied to
individual patients
A 95% CI gives an indication of the precision of the
estimated MIC value in this group of patients. One might
question whether it is useful to present these CIs, especially
because it is known that MIC values found under different
circumstances may differ considerably. It has, for example,
been shown that MIC values are dependent on baseline
values. With higher baseline values (indicating more severe
complaints), the change on the measurement instrument is
found to be greater before patients label it as a minimally
important improvement on the anchor [30,31]. In addition,
it has been found that the MIC values for improvement and
deterioration are not always the same [25]. And finally, the
choice of the anchor [32] and the type of population [26]
influence the resulting MIC value. Thus, it can be argued
that presenting narrow CIs around the estimated MIC value
might introduce a false sense of confidence. However, as
long as one realizes the meaning of a 95% CI, that is, to
give insight into the precision in the MIC estimation
because of sample variation in that particular study, it is
informative. Especially with regard to the current recom-
mendation to assess MIC values with different methods,
using different anchors [10,11,33], which hopefully trian-
gulate to one MIC value or a small range of MIC values,
knowing the 95% CI around the estimations is very useful.
The values of sensitivity and specificity at the optimal
ROC point, that is, the chosen MIC value, also have direct
bearing on the certainty with which the MIC value can be
applied to individual patients: high sensitivity and specific-
ity values minimize the probabilities of misclassification.
We advise against the application of the MIC to individual
patients when sensitivity and specificity are less than 75%.
Observing whether the MIC values exceed the measure-
ment error also has an impact on the interpretation of MIC
in individual patients. If the questionnaire Q is known to have
a substantial measurement error, then observed changes in in-
dividual patients, although higher than the MIC value, may
still be attributed to measurement error. Note that this was
the case in our fictive example, where the MIC value of
10.5 did not exceed the SDC. What should we conclude in
these situations? The main conclusion is that the measure-
ment instrument is not suitable as a guide in the clinical man-
agement of an individual patient. If it is used, nevertheless,
one has a high chance of measurement error.5. Conclusion
The MIC values determined in groups of patients can be
applied to individual patients. The ROC method, comple-
mented by a graph of the anchor-based MIC distribution,
provides all the necessary information for the quantification
of the uncertainty when MIC values are applied to individual
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